Retraction: Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-κB Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer
- PMID: 30217881
- DOI: 10.1158/0008-5472.CAN-18-1170
Retraction: Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-κB Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer
Retraction of
-
Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.Cancer Res. 2007 Apr 1;67(7):3310-9. doi: 10.1158/0008-5472.CAN-06-4277. Cancer Res. 2007. Retraction in: Cancer Res. 2018 Sep 15;78(18):5471. doi: 10.1158/0008-5472.CAN-18-1170. PMID: 17409440 Retracted.
Comment in
-
Findings of Research Misconduct.Fed Regist. 2020 Aug 12;85(156):48709-48713. Fed Regist. 2020. PMID: 32831427 Free PMC article. No abstract available.
Similar articles
-
Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.Cancer Res. 2007 Apr 1;67(7):3310-9. doi: 10.1158/0008-5472.CAN-06-4277. Cancer Res. 2007. Retraction in: Cancer Res. 2018 Sep 15;78(18):5471. doi: 10.1158/0008-5472.CAN-18-1170. PMID: 17409440 Retracted.
-
Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.Cancer Res. 2007 Dec 1;67(23):11377-85. doi: 10.1158/0008-5472.CAN-07-2803. Cancer Res. 2007. Retraction in: Cancer Res. 2018 Sep 15;78(18):5469. doi: 10.1158/0008-5472.CAN-18-1173. PMID: 18056465 Retracted.
-
Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.Toxicol In Vitro. 2010 Oct;24(7):1927-34. doi: 10.1016/j.tiv.2010.08.002. Epub 2010 Aug 7. Toxicol In Vitro. 2010. PMID: 20696233
-
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. doi: 10.2174/1568011033353452. Curr Med Chem Anticancer Agents. 2003. PMID: 12678905 Review.
-
NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?J Cell Biochem. 2004 Jan 1;91(1):100-17. doi: 10.1002/jcb.10729. J Cell Biochem. 2004. PMID: 14689584 Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous